This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Materials and Methods Oncology-trained nurses review the charts of all specialty oncology medications that are due to be refilled. The nurses have access to the electronic medicalrecord and perform an extensive medicalrecords review of office notes, labs, scans, pathology, and upcoming appointments.
The authors examined the safety, feasibility, and toxicity management of delivering both SUD and target doses in outpatient settings, offering institutional guidance for optimizing patient care and reducing hospitalization burden. However, the feasibility and safety of expanding these regimens to outpatient (OP) settings remain underexplored.
Academic medical centers continue to conduct the bulk of trials, especially in the US, while community hospitals and clinics often lack the resources to participate in trials at scale. This is despite the majority of patients being treated at community hospitals and clinics. per year and multinational studies rising by 4.9%
Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. These will undoubtedly present great opportunities for hospital pharmacists and their teams.
Karl-Johan Lindner and Marie Halvarsson, from the pharmacy at Västerås Hospital in Sweden, describe a new approach to improve the categorisation of medication errors that uses the skills of hospital pharmacists to reclassify reported incidents based on a given medication process. One million injections or infusions and 1.7
There is a considerable way to go in Europe to move towards more automated medication management systems in hospitals, according to the results of a survey run by a European Association of Hospital Pharmacists (EAHP) special interest group (SIG). This survey report helps us understand the current status of automation in Europe.
Katie Joyce and colleagues describe how their hospital pharmacy team in the north of England worked collaboratively across the primary-secondary care interface to implement shared care agreements for a cohort of 270 patients prescribed amiodarone to optimise the patient experience, overcome operational challenges and streamline processes.
The intention is to streamline the process for patients wishing to access their medicalrecords via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. When will it come into force?
5G technology can recommend the next steps during surgical procedures based on the latest medical research and facilitate real-time consultations with remote healthcare professionals. Hospitals avoided pouring money into costly inventory monitoring systems due to tight budgets and the limited return on investment.
If these results can be integrated into a patient’s medicalrecords, they can be used to inform the prescription of future medicines throughout that patient’s life. 2024 NHS England. The post Pharmacogenetics: What pharmacists need to know appeared first on Hospital Pharmacy Europe. Introduction to pharmacogenetics.
The update to the app is part of a series of measures unveiled in the Plan for Digital Health and Social Care that describes how technologies will be used to “drive efficiency, free up hospital space and clinician time, and bust the Covid backlogs.”
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content